Laddar...
Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma
The efficacy of sorafenib in combination with transarterial chemoembolization (TACE) or multiple-line therapies in patients with advanced hepatocellular carcinoma (HCC) remains unclear. This study aimed to investigate the overall survival (OS) of patients with advanced HCC in response to different c...
Sparad:
| I publikationen: | Medicine (Baltimore) |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Wolters Kluwer Health
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6636964/ https://ncbi.nlm.nih.gov/pubmed/31232945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016074 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|